Results 191 to 200 of about 2,061,669 (219)

Seizing the moment: the potential of PrEP choice and innovation to transform HIV prevention. [PDF]

J Int AIDS Soc
Schmidt HA, Prochazka M, Ingold H, Reza-Paul S, Chidarikire T, Romyco I, Rodolph M.   +6 more
europepmc   +1 more source

Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study). [PDF]

Eur Thyroid J
Puliani G, Bianchini M, Giani C, Valerio L, Nervo A, Sapuppo G, Grani G, Dalmiglio C, De Leo S, Lauretta R, Mormando M, Terrenato I, Zovato S, Fugazzola L, Castagna MG, Durante C, Pellegriti G, Arvat E, Elisei R, Appetecchia M.   +19 more
europepmc   +1 more source

Development of a Next-Generation Sequencing Protocol for Assessing Lenacapavir Resistance in HIV-1 Capsid. [PDF]

J Med Virol
El Khalili O, Chenwi CA, Spalletta D, Marchegiani G, Carioti L, Moghadam HE, Bertoli A, Spagnuolo V, Santoro MM, Ceccherini-Silberstein F, Bellocchi MC.   +10 more
europepmc   +1 more source

The Use of Nonhuman Primate Models for Advancing HIV PrEP. [PDF]

Viruses
Bekerman E, Callebaut C.
europepmc   +1 more source

Contemporary antiretroviral pharmacology in the male genital tract: implications for HIV treatment and prevention. [PDF]

Antimicrob Agents Chemother
Neverette NC, Winfield J, Chaparro-Cáceres N, Ho KS, Dumond JB, Devanathan AS.   +5 more
europepmc   +1 more source

Modelling the 5-Year Impact of Twice-Yearly Injectable Lenacapavir for HIV Pre-Exposure Prophylaxis in the United States. [PDF]

J Int AIDS Soc
Moore M, Lee S, Matrajt L, Stansfield SE, Tao L, Yang J, Mezzio D, Jarrett J, Castro JC, Hsiao A, Zachry W, Dimitrov D.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis

Journal of Hepatology, 2020
Liza Coyer, Anders Boyd, Elske Hoornenborg   +2 more
exaly